Prot #000133: Sepsis-ACT: A Double-blind, Randomised, Placebo-controlled, Phase 2b/3 Adaptive Clinical Trial Investigating the Efficacy and Safety of Selepressin as Treatment for Patients with Vasopressor-dependent Septic Shock
- Wunderink, Richard G (PD/PI)
Project: Research project